Related Experiment Video
Updated: Aug 30, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Spinally delivered N-, P/Q- and L-type Ca2+-channel blockers potentiate morphine analgesia in mice
Tadaoki Fukuizumi1, Tsuyako Ohkubo, Kenji Kitamura
1Department of Physiological Science and Molecular Biology, Fukuoka Dental College, 2-15-1 Tamura, Sawara, Fukuoka 814-0193, Japan.
Abstract:
We studied the antinociceptive effects induced at the spinal level by N-, P/Q- and L-type voltage-dependent Ca2+-channel (VDCC) blockers given alone or in combination with morphine, the test responses being the algesic ones induced by acute thermal and mechanical stimuli. When given alone, intrathecal omega-agatoxin IVA (P/Q-type blocker) produced a potent dose-dependent inhibition in the tail-flick and tail-pressure over the dose range 0.33-33 pmol/mouse. Omega-conotoxin GVIA (N-type blocker) also produced dose-dependent inhibitions, but its antinociception against thermal stimuli was weaker than against mechanical stimuli. Calciseptine (L-type blocker) slightly reduced both nociceptive responses, but only at 33 pmol. At their subthreshold doses, intrathecal omega-agatoxin IVA, omega-conotoxin GVIA and calciseptine each significantly enhanced morphine analgesia in the tail-flick and tail-pressure tests, the rank order of potencies being N-> or =P/Q->L-type. These results indicate that combining a low-dose VDCC blocker, especially the N- or P/Q-type, with morphine may be a very useful way of minimizing the dose of morphine and may reduce side effects.
Insights
Combining spinal voltage-dependent calcium channel (VDCC) blockers with morphine enhances pain relief. Specifically, N- and P/Q-type VDCC blockers significantly boosted morphine
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Voltage-dependent calcium channels (VDCCs) play a crucial role in pain signaling at the spinal level.
- Morphine is a primary analgesic, but its efficacy can be limited by side effects and tolerance.
Purpose of the Study:
- To investigate the antinociceptive effects of spinal N-, P/Q-, and L-type VDCC blockers, alone and in combination with morphine.
- To determine if VDCC blockers can potentiate morphine's analgesic effects and potentially reduce required morphine dosage.
Main Methods:
- Intrathecal administration of omega-agatoxin IVA (P/Q-type), omega-conotoxin GVIA (N-type), and calciseptine (L-type) VDCC blockers in mice.
- Assessment of antinociception using tail-flick (thermal) and tail-pressure (mechanical) tests.
- Evaluation of the combined effects of subthreshold doses of VDCC blockers with morphine.
Main Results:
- Intrathecal omega-agatoxin IVA and omega-conotoxin GVIA demonstrated potent dose-dependent antinociception against both thermal and mechanical stimuli.
- Omega-conotoxin GVIA showed stronger antinociception against mechanical stimuli compared to thermal stimuli.
- Subthreshold doses of N- and P/Q-type VDCC blockers significantly enhanced morphine analgesia, with a potency order of N- or P/Q-type greater than or equal to L-type.
Conclusions:
- Spinal N- and P/Q-type VDCC blockers exhibit significant antinociceptive properties.
- Combining low doses of N- or P/Q-type VDCC blockers with morphine offers a promising strategy for potentiating analgesia.
- This combination approach may allow for reduced morphine dosage, potentially mitigating associated side effects.
More Related Videos
05:24In Vivo SiRNA Transfection and Gene Knockdown in Spinal Cord via Rapid Noninvasive Lumbar Intrathecal Injections in Mice
Published on: March 22, 2014
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Local Anesthetics: Clinical Application as Spinal Anesthesia
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview